RadNet's DeepHealth complete acquisition of iCAD
RadNet (RDNT) announced that it has completed the acquisition of iCAD (ICAD). The integration of iCAD's complementary commercial, technology, and regulatory capabilities into DeepHealth advances DeepHealth's mission to address clinical and operational challenges in screening and diagnosis by harnessing the power of AI and imaging. Kees Wesdorp, President and CEO of RadNet's Digital Health segment, commented, "We are excited to welcome the iCAD team to DeepHealth. The integration of iCAD further empowers DeepHealth to meet the real-world clinical needs of today, from improving the accuracy and early detection of breast cancer to orchestrating large-scale screening programs, while shaping the future of breast cancer management. Our combined capabilities position us for accelerated growth and rapid delivery of transformative, AI-powered population health solutions."
